Clinical trials: Insomnia Due to Anxiety and Fear
Insomnia Due to Anxiety and Fear
Therapeutic Effect of Self-administered Auricular Acupressure on Insomnia Induced by Anxiety
This is a sham-controlled randomized trial to identify the effectiveness of treating insomnia induced by anxiety with self-administered auricular acupressure in Malaysia.
- Trial name
- NCT05152095
- Testing
- Vaccaria seed (Wang Bu Liu Xing) pre-attached to adhesive tape used for auricular acupressure, Plain ear adhesive tape
- Where
- Malaysia
- Volunteers
- 112 people
- Sponsor
- IMU University, Malaysia
Insomnia Due to Anxiety and Fear
Remote Yoga Nidra for Anxiety and Sleep
The goal of this application is to collect survey data indicating the effects of a digital Yoga Nidra practice on anxiety and sleep during COVID-19. We will explore effects on momentary anxiousness, as well as on sleep.
- Trial name
- NCT04571593
- Testing
- Yoga Nidra
- Where
- United States
- Volunteers
- 74 people, healthy volunteers welcome
- Sponsor
- National University of Natural Medicine
Insomnia Due to Anxiety and Fear
The Impact of Attentive System on Sleep Reactivity
Sleep Reactivity is defined as the degree to which a given amount of stress disrupts the sleep system, and it is consistent over time and across different type of stimuli.
- Trial name
- SREEG (NCT06694818)
- Testing
- trauma film paradigm
- Where
- Italy
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- IRCCS San Raffaele
Sleep Disturbance, Insomnia
The CANabidiol Use for RElief of Short Term Insomnia
This study aims to investigate the effect of 50 mg and 100 mg per day oral CBD product versus a placebo over 8 weeks on insomnia severity in adults aged 18-65 years old with insomnia symptoms.
- Conditions
- Sleep Disturbance, Insomnia, Insomnia Type; Sleep Disorder, Insomnia, Transient
- Trial name
- CANREST (NCT05253417)
- Testing
- 50 mg Cannabidiol (CBD), 100 mg Cannabidiol (CBD)
- Where
- 2 sites in Australia
- Volunteers
- 208 people
- Sponsor
- Bod Australia
Chronic Insomnia, Sleep Deprivation
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
This clinical trial aims to evaluate the safety and efficacy of PROSOMNIA Sleep Therapy (PSTx) for individuals suffering from chronic insomnia, sleep deprivation, and REM sleep disorders.
- Conditions
- Chronic Insomnia, Sleep Deprivation, REM Behavior Disorder, REM Sleep Behavior Disorder
- Trial name
- PSHW (NCT06644573)
- Testing
- PROSOMNIA Sleep Therapy™ (PSTx), Anesthesia-Induced Sleep Therapy, Diprivan (propofol), Astra-Zeneca
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Nyree Penn
Insomnia Due to Anxiety and Fear
Stress-induced Sleep Deficits and a Complementary Therapy
The COVID-19 pandemic and social isolation order induced stress/anxiety as well as cellphone dependence. As a result, sleep disruption and mental distress became major health concerns.
- Trial name
- Sleep-Aid (NCT05280561)
- Testing
- DHM
- Where
- China
- Volunteers
- 288 people, healthy volunteers welcome
- Sponsor
- University of Southern California